Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomecompanyN-(4-Hydroxyphenyl)Prop-2-Enamide [34443-04-4]
N-(4-Hydroxyphenyl)Prop-2-Enamide
N-(4-Hydroxyphenyl)Prop-2-Enamide

N-(4-Hydroxyphenyl)Prop-2-Enamide [34443-04-4]

Price Get Latest Price
Packge 1kg25kg200kg
  • Min. Order:1kg
  • Supply Ability:10000kg per Month
  • Time:2022-08-17

Product Details

  • Product NameN-(4-Hydroxyphenyl)Prop-2-Enamide
  • CAS No.34443-04-4
  • EINECS No.252-026-9
  • MFC9H9NO2
  • MW163.17
  • Boiling point 385.9±34.0 °C(Predicted)
  • density 1.231±0.06 g/cm3(Predicted)
Name
N-(4-Hydroxyphenyl)Prop-2-Enamide
Synonyms
N-(4-Hydroxyphenyl)Acrylamide; Acrylanilide, 4'-Hydroxy-; Brn 2638744

Molecular Structure

Molecular Formula
C9H9NO2
Molecular Weight
163.18
CAS Registry Number
34443-04-4
EINECS











Company Profile Introduction

Shanghai Qyubiotech Co., Ltd. was established in 2015, focuses on the research, produced and customization of pharmaceutical intermediates,advanced chemicals in new materials and new energy sources. Our team has a wealth of product development, production experience, can produce a rapid development of customer demand for products, and can be difficult to undertake custom synthesis projects.

Especially in Functional intermediates of Adamantane derivatives series, Styrene derivatives series, Acrylate derivatives series etc; Material intermediates of Carbazole series, Naphthalene series, Anthracene series, Fluorene series etc; Pharmaceutical intermediates of Boric acid series, Fluorine series, Aromatic ketone series etc.  

Professional and Efficient technical team, High-quality strict quality control system, Perfect after-sales service system, To ensure the quality of every product and every customer satisfaction!

  • Since:2015-03-27
  • Address: Room 1788, Building 5 No.111 Fengpu Dadao Fengpu Industrial Park Fengxian District Shanghai China
INQUIRY